IRWD

Latest SEC Filings & News for IRWD

1 most recent filing and news item mentioning IRWD. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day
curl "https://api.brieftape.com/v1/tickers/IRWD/news?limit=20"

Pull IRWD filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

IRONWOOD RAISES 2026 GUIDANCE AMID STRONG LINZESS SALES

Ironwood Pharmaceuticals raised total revenue and adjusted EBITDA guidance for 2026, citing strong LINZESS performance, while also repaying convertible notes and initiating a confirmatory Phase 3 trial for apraglutide.

View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.